Collaboration with TELUS Health enables KITS to deliver direct billing to 38 insurance companies, covering 70 per cent of Canadians VANCOUVER, BC, June 3, 2024 /CNW/ - Kits Eyecare Ltd. (TSX: KITS) ("KITS" or the "Company"), the leading vertically integrated eyecare provider, has announced a collaboration with TELUS Health - a global healthcare leader providing comprehensive physical, mental and financial wellbeing services and solutions, to offer direct billing for 38 insurance companies, covering over 70 per cent of Canadians. With this partnership, KITS now offers the widest direct billing coverage in Canada for the optical category.

SUNNYVALE, Calif., June 3, 2024 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients, announces a brokered private placement offering (the "Offering") of up to 30,000,000 units ("Units") of Willow at an issue price of C$0.10 per Unit (the "Offering Price") to raise aggregate gross proceeds of up to C$3.0 million. Independent Trading Group (ITG) Inc. (the "Agent") has agreed to act as lead agent and sole bookrunner on a "best efforts" basis in connection with the Offering.

TORONTO, June 3, 2024 /CNW/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") announced today that it will hold its Annual General Meeting of Shareholders (the "Meeting") on Friday, June 28, 2024 at 10:00 a.m. EST at the offices of McCarthy Tétrault LLP, Suite 5300, TD Bank Tower, Toronto, Ontario M5K 1E6.

VANCOUVER, BC, May 31, 2024 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is pleased to announce the voting results from its annual general meeting of shareholders (the "Meeting"), held earlier today.  A total of 50,266,506 common shares representing 15.68% of the 320,551,600 issued and outstanding common shares of the Company as at the record date of April 2, 2024, were represented either in person or by proxy at the Meeting.